{"id":38148,"date":"2026-07-16T19:20:00","date_gmt":"2026-07-16T17:20:00","guid":{"rendered":"http:\/\/stocks-future.com\/?guid=231a9e09cc120b9b4c3dca82ee896df3"},"modified":"2026-07-16T19:20:00","modified_gmt":"2026-07-16T17:20:00","slug":"robbins-llp-urges-nnox-stockholders-to-contact-the-firm-for-information-about-the-class-action-against-nano-x-imaging-ltd-3","status":"publish","type":"post","link":"https:\/\/stocks-future.com\/?p=38148","title":{"rendered":"Robbins LLP Urges NNOX Stockholders to Contact the Firm for Information About the Class Action Against Nano-X Imaging Ltd.\u00a0"},"content":{"rendered":"

SAN DIEGO--(BUSINESS WIRE)--$NNOX<\/a> #Health<\/a>--Robbins LLP<\/a> reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nano-X Imaging Ltd. (NASDAQ: NNOX) securities between March 31, 2025 and April 17, 2026. Nano-X develops a commercial-grade tomographic imaging device with a digital X-ray source.<\/p><\/a><\/a>

For more information, submit a form<\/a>, email<\/a> attorney Aaron Dumas, Jr., or give us a call at (800) 350-6003.<\/p>

The Allegations:<\/b> Shareholders allege that Nano-X Imaging Ltd. (NNOX) misled investors regarding its manufacturing operations and financial condition. According to the complaint, during the class period, defendants failed to disclose that:<\/p>

  1. defendants overstated purported efficiency gains achieved in Nano- X\u2019s operations, as well as the purported increased demand for its products;<\/li>
  2. Nano-X\u2019s production and manufacturing operations were poorly aligned with demand for the Company\u2019s products;<\/li>
  3. Nano-X was experiencing significantly increased operating expenses and cash burn;<\/li>
  4. the foregoing significantly increased the likelihood that Nano-X would be forced to take disruptive remedial measures with respect to its manufacturing operations, entailing significant restructuring and impairment charges; and<\/li>
  5. defendants\u2019 public statements were materially false and misleading at all relevant times.<\/li><\/ol>

    Plaintiff alleges that on April 20, 2026, Nano-X issued a press release announcing its fourth quarter (\u201cQ4\u201d) 2025 financial results and business updates, reporting, inter alia, a Q4 net loss of $33.4 million, mainly due to a $17.5 million charge attributed to impairment of long-lived assets following a restructuring initiative at its Korean chip manufacturing facility. In explaining the restructuring charge, the press release acknowledged that Nano-X needed to \u201cshift[] to a more efficient outsourced production model that is better aligned with current and anticipated demand.\u201d The press release also announced that Nano-X\u2019s then-Chief Financial Officer would step down effective July 31, 2026. On this news, the price of Nano-X\u2019s stock price fell $0.695 per share, or 24.39%, to close at $2.155 per share on April 20, 2026.<\/p>

    What Now<\/b>: You may be eligible to participate in the class action against Nano-X Imaging Ltd. Shareholders who wish to serve as lead plaintiff for the class must submit their papers to the court by August 11, 2026. The lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation. You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member. For more information, click here<\/a>.<\/p>

    All representation is on a contingency fee basis. Shareholders pay no fees or expenses.<\/b><\/i><\/p>

    About Robbins LLP<\/b>: A recognized leader in shareholder rights litigation, the attorneys and staff of Robbins LLP<\/a> have been dedicated to helping shareholders recover losses, improve corporate governance structures, and hold company executives accountable for their wrongdoing since 2002.<\/p>

    To be notified if a class action against Nano-X Imaging Ltd. settles or to receive free alerts when corporate executives engage in wrongdoing, sign up for Stock Watch<\/a> today.<\/p>

    Attorney Advertising. Past results do not guarantee a similar outcome.<\/p> Contacts<\/b>

    Aaron Dumas, Jr.Robbins LLP5060 Shoreham Pl., Ste. 300San Diego, CA 92122adumas@robbinsllp.com<\/a>(800) 350-6003www.robbinsllp.com<\/a><\/p>","protected":false},"excerpt":{"rendered":"

    SAN DIEGO–(BUSINESS WIRE)–$NNOX #Health–Robbins LLP reminds stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Nano-X Imaging Ltd. (NASDAQ: NNOX) securities between March 31, 2025 and April 17, …<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-38148","post","type-post","status-publish","format-standard","hentry","category-infos-businesswire"],"_links":{"self":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38148","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=38148"}],"version-history":[{"count":3,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38148\/revisions"}],"predecessor-version":[{"id":38155,"href":"https:\/\/stocks-future.com\/index.php?rest_route=\/wp\/v2\/posts\/38148\/revisions\/38155"}],"wp:attachment":[{"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=38148"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=38148"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/stocks-future.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=38148"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}